Can QuantiFERON Gold Test Be Positive for MAC?
No, the QuantiFERON-TB Gold test is generally NOT positive in patients with Mycobacterium avium complex (MAC) infection, with only about 2% positivity in MAC disease. 1, 2
Key Evidence
The QuantiFERON-TB Gold tests (QFT-G and QFT-GIT) use specific antigens—ESAT-6, CFP-10, and TB7.7—that are present in M. tuberculosis but absent from most nontuberculous mycobacteria, including MAC 1. This design specifically improves test specificity by avoiding cross-reactivity with MAC organisms.
Clinical Data Supporting Low Cross-Reactivity
- In patients with MAC disease (M. avium-intracellulare complex), the QFT positivity rate is only 2% 2
- A prospective study showed QFT-G was positive in only 34.3% of MAC patients, compared to 89.5% in TB patients 3
- The low positivity in MAC patients likely represents concurrent latent TB infection rather than cross-reactivity with MAC itself 3
Important Caveats
When False-Positives CAN Occur
While MAC does not cause positive results, certain other nontuberculous mycobacteria DO cross-react 1:
These organisms possess ESAT-6 and CFP-10 antigens, causing false-positive IGRA results 1.
Clinical Interpretation in TB-Endemic Areas
A positive QuantiFERON in a MAC patient most likely indicates coexistent latent TB infection, not cross-reactivity with MAC. This is particularly relevant in intermediate or high TB burden countries where background TB infection rates are elevated 3. The study found that IGRAs could not discriminate between active TB and MAC disease in patients who also had latent TB infection 3.
Practical Algorithm
When interpreting QuantiFERON results in suspected MAC:
- Positive QFT + MAC isolated: Consider concurrent latent TB infection (especially in TB-endemic areas) rather than false-positive from MAC
- Negative QFT + MAC isolated: Consistent with MAC disease without TB co-infection
- If patient has M. kansasii, M. marinum, or M. szulgai: Expect potential false-positive QFT results
The QuantiFERON test remains highly specific for distinguishing TB from MAC disease, making it a useful adjunct when differentiating between these two infections.